Abstract: A mat washer includes: a body adapted for highway transport; a loading platform adapted to receive a stacked pair of mats from, for example, a forklift, and adapted to pivot the pair of mats to an upright position; a splitter adapted to receive the mats from the loading platform and to separate the mats from one another; a transporter adapted to transport each of the mats longitudinally relative to the body from the splitter; a uniter adapted to receive the mats from the transporter and urge them together; an unloading platform adapted to receive the pair of mats from the uniter and pivot them downwardly for retrieval by, for example, the forklift; and a washing facility disposed between the loading and the unloading platform and adapted to wash the mats.

Abstract: A system for delivering content to a user based on geolocation may include a user device with a location sensor and a software application. The system may include a server, including executable instructions configured to execute a tour module. The server may include a data storage, including user data and tour data stored thereon. The tour data may include a point of interest (POI) data object, including location data and content data. The software application may be configured to obtain a location of the user device from the location sensor and send the location to the tour module. The tour module may be configured to determine, from the location of the user device, that the user device is within a geo-fence of the POI data object and send the content data to the software application. The software application may be configured to display the content data on the user device.

Abstract: A mat washer includes: a body adapted for highway transport; a loading platform adapted to receive a stacked pair of mats from, for example, a forklift, and adapted to pivot the pair of mats to an upright position; a splitter adapted to receive the mats from the loading platform and to separate the mats from one another; a transporter adapted to transport each of the mats longitudinally relative to the body from the splitter; a uniter adapted to receive the mats from the transporter and urge them together; an unloading platform adapted to receive the pair of mats from the uniter and pivot them downwardly for retrieval by, for example, the forklift; and a washing facility disposed between the loading and the unloading platform and adapted to wash the mats.

Abstract: Compounds of general formula: wherein R1, R2 and R3 are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of formula I or pharmaceutically acceptable salts thereof: wherein X, A, R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: A head protection system comprises a helmet shell, a visor mounting for pivotally mounting a visor to the shell to enable the visor to be moved between raised and lowered positions, and a retainer for releasably retaining the visor to the helmet. The system includes a visor adapted for mounting on the shell which comprises a substrate of transparent thermoplastic material and a backing substrate comprising a plurality of layers of high performance, ballistic resistant material. The system may further include a second visor which can be releasably connected to the shell using the same visor mounting and which may have a different construction and primary function.

Abstract: A structural member for use in extremely high temperature environments that has substantially flat exterior for resting on a flat surface. The substantially flat exterior of the structural member has a low angle chamfer that is preferably less than 45 degrees and that rises far enough above the flat surface so that when the edge is rolled using conventional processing methods, the resulting high point does not extend a distance far enough to contact with the surface.

Abstract: Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, R5, and G are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4 and Z are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein R1, R2 and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3 and Ar are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3, and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of general formula: wherein R1, R2 and R3 are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of formula (I) wherein RF1, RF2, Z, R1, R2, Ar, X and Y are as dcfined in thc specification as wcll as salts and pharmaceutical compositions including the compounds were prepared. These compounds are useful in therapy, in particular in the management of pain.

Abstract: Compounds of Formulae (IA), (IB) or pharmaceutically acceptable salts thereof; wherein Het, X1, R1, R2, R3, R3a and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of Formula (I) or pharmaceutically acceptable salts thereof; wherein R1, R2, R3, R4, n and Ar are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4 and Z are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.